Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 20/20 | 0.58 |
| ▸ | ITGA4 | P13612 | 20/20 | 0.58 |
| ▸ | ITGB7 | P26010 | 4/20 | 0.51 |
| ▸ | ITGAV | P06756 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2770017 | 0.93 | ITGB1 (0.59) | ITGB1ITGA4ITGB7ITGAV | |
| SCHEMBL6038572 | 0.92 | ITGB1 (0.60) | ITGB1ITGA4ITGB7ITGAV | |
| SCHEMBL6038359 | 0.90 | ITGB1 (0.60) | ITGB1ITGA4ITGB7 | |
| SCHEMBL6038415 | 0.89 | ITGB1 (0.58) | ITGB1ITGA4ITGB7 | |
| SCHEMBL6038880 | 0.89 | ITGB1 (0.67) | ITGB1ITGA4ITGB7 | |
| SCHEMBL2770070 | 0.87 | ITGB1 (0.60) | ITGB1ITGA4ITGB7ITGAV | |
| SCHEMBL2770374 | 0.86 | ITGB1 (0.60) | ITGB1ITGA4ITGB7ITGAV | |
| SCHEMBL6038647 | 0.85 | ITGB1 (0.56) | ITGB1ITGA4ITGB7 | |
| SCHEMBL2769873 | 0.85 | ITGB1 (0.64) | ITGB1ITGA4ITGB7ITGAV | |
| SCHEMBL2769474 | 0.84 | ITGB1 (0.63) | ITGB1ITGA4ITGB7ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060004019-A1 | Steroid sparing agents and methods of using same | BIOGEN IDEC INTERNATIONAL HOLDING LTD. (BM) | 2006-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060004019-A1 | Steroid sparing agents and methods of using same | IL5, FCER2, CD40 | ITGB1 305/4885ITGA4 298/4885ITGB7 485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.